Navigation Links
Assured Pharmacy Receives $500,000 in Debt Financing
Date:9/14/2010

FRISCO, Texas, Sept. 14 /PRNewswire-FirstCall/ -- Assured Pharmacy (Pink Sheets: APHY), a pharmacy service healthcare organization operating a chain of specialty pharmacies providing advanced prescription medication fulfillment solutions to sufferers of chronic pain, is pleased to announce that it has received $500,000 of debt financing from an existing shareholder which can be converted in whole or in part anytime over the 2 year term at the holder's option into a maximum of 500 shares of the Company's Series A Preferred Stock.  Interest on the debt, which is payable in shares of the Company's Common Stock, accrues on the unconverted principal amount outstanding from time to time at the rate of ten percent (10%) per annum and is payable to the holder on a quarterly basis and on the maturity date, which is July 20, 2012.  

This financing is supporting the Company's ongoing business expansion and investment into solidifying its supply chain of prescription medications. "We believe that this investment from our existing shareholder validates their confidence in our business model and supports our corporate actions enacted over the past 18 months," stated Mr. Robert DelVecchio, Chief Executive Officer of Assured Pharmacy.  "We are very pleased to have the support of this investment as we enter the next phase of our business model.  As we lay the foundation for expanding our pharmacy footprint into new markets, improving our financial position with suppliers is critical and this financing furthers that requirement.  We expect to provide further updates shortly and are pleased to have secured this financing arrangement in an economic cycle which proves difficult to secure funds on favorable terms."

About Assured PharmacyAssured Pharmacy, Inc. is a growing chain of specialty pharmacies that provide advanced prescription services to a diverse array of medical professionals and their patients. Assured Pharmacy is committed to providing these physicians and patients with a better prescription process through four community locations.  This enhanced process is achieved by blending our specialized service model with focused pharmacology.  Our business model targets physicians specializing in pain management – anesthesiology, orthopedics, neurology, oncology, psychiatry, physical rehabilitation and industrial medicine. The focus is on treating patients with long-term, acute, chronic pain conditions.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934.
These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management.
Therefore, actual results could differ materially from the forward-looking statements contained in this press release.
A wide variety of factors that may cause actual results to differ from the forward-looking statements include, but are not limited to, the following: the Company's ability to increase revenue and profits in the current economic climate; the effect of changing economic conditions; lack of sufficient financing for opening new pharmacies; inability to manage growth; and changes in government regulations, controls and similar matters.
These cautionary statements should not be construed as exhaustive or as any admission as to the adequacy of the Company's disclosures.
The Company cannot predict or determine after the fact what factors would cause actual results to differ materially from those indicated by the forward-looking statements or other statements.
The reader should consider statements that include the words "believes", "expects", "anticipates", "intends", "estimates", "plans", "projects", "should", or other expressions that are predictions of or indicate future events or trends, to be uncertain and forward-looking.
The Company does not undertake to publicly update or revise forward-looking statements, whether as a result of new information, future events or otherwise.CONTACT INFORMATIONMr. Robert DelVecchioChief Executive OfficerAssured Pharmacy, Inc.(214) 220-9302 investors@assuredrxservices.comwww.assuredrxservices.com
'/>"/>

SOURCE Assured Pharmacy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Assured Pharmacy Reports Same Store Sales for the Month of July 2010
2. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
3. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
4. Diplomat Specialty Pharmacy Honored by Inc. Magazine as One of the Nations Fastest-Growing Companies
5. Pharmacy Franchise Owners Association Taps David Mayper as Executive Director
6. NACDS, NCPA: Victory for Patients, Pharmacy as CMS Moves to Withdraw Provisions of AMP Rule Currently Blocked by Injunction
7. Pharmacy Times Launches iPad Edition
8. Canadian Pharmacy Intermediary SaveRxCanada.com Enhances Online Shopping System
9. Graymark Healthcare Agrees to Sell Pharmacy Division to Walgreens Creating Pure Play Sleep Apnea Company
10. NCPA Launches www.PharmacyMatching.com to Connect Independent Pharmacy Buyers and Sellers
11. Low Installation Rates in Retail Pharmacies Across Europe Increase the Growth Potential of the Pharmacy Automation Systems Market, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... 2017   West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today shared the results of a study ... the intradermal administration of polio vaccines. The study results ... May 2017 by Dr. Ondrej Mach , Clinical ... Organization (WHO), and recently published in the journal ...
(Date:10/4/2017)... Oct. 4, 2017  According to the Centers for Disease Control and ... October . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the ... certain health insurance regulations. ... time to get a flu shot is by the end of October, ...
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
Breaking Medicine Technology:
(Date:10/13/2017)... Milwaukee, WI (PRWEB) , ... October 13, 2017 , ... ... movement in medicine known as “patient engagement.” The patient is doing more than filling ... research partners. , “There is an increasing emphasis in health care and research ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
Breaking Medicine News(10 mins):